AXQ Capital’s AC Immune ACIU Stock Holding History

AXQ Capital’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.7K	Buy	+10,398	New	+$28.6K	﹤0.01%	940

Other funds holding ACIU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BCV

Banque Cantonale Vaudoise Lausanne, Switzerland $722M AUM 30.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

AXQ Capital's ACIU Position: Q2 2026 in Review

AXQ Capital opened a new position in AC Immune (ACIU) in Q2 2026: 10,398 shares worth $24.7K. The stake represents ﹤0.01% of the portfolio and ranks #940 among its holdings.

20 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

AXQ Capital held 10,398 shares of AC Immune worth $24.7K as of Q2 2026.
AC Immune was a new AXQ Capital position in Q2 2026.
AC Immune made up ﹤0.01% of AXQ Capital's portfolio in Q2 2026, its #940 holding.
20 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.